Does the CTLA4 rs3087243 A allele reduce CTLA-4 inhibitory signaling and worsen immune balance during chronic stress?

The CTLA4 rs3087243 variant (also known as CT60) is a well-studied single nucleotide polymorphism that influences the inhibitory capacity of the adaptive immune system. Research indicates that this variant plays a significant role in modulating T-cell regulation, particularly during periods of physiological or psychological stress.

Clinical and genetic evidence

The rs3087243 polymorphism involves an A to G substitution in the 3' untranslated region (UTR) of the CTLA4 gene.

• Genotype Impact: The "A" allele is consistently associated with lower mRNA expression and reduced protein trafficking of CTLA-4 to the T-cell surface compared to the "G" allele.
• Functional Suppression: In functional assays, T cells from individuals with the A/A genotype demonstrate a significantly reduced ability to suppress proliferation (p = 0.019) compared to those with the G/G genotype.
• Clinical Associations: Due to this reduced inhibitory signal, the A allele is linked to an increased susceptibility to various autoimmune conditions where T-cell regulation is compromised, such as Graves' disease and Type 1 diabetes.

Mechanistic explanations

CTLA-4 is a primary checkpoint molecule that maintains immune homeostasis through several key pathways:

• Ligand Competition and Removal: CTLA-4 has a higher affinity for CD80/CD86 ligands on antigen-presenting cells than the stimulatory receptor CD28. It also actively removes these ligands via trans-endocytosis, effectively "starving" T cells of the costimulatory signals needed for activation.
• Signal Transduction: Reduced CTLA-4 signaling leads to unchecked T-cell receptor (TCR) signaling and a shift toward a pro-inflammatory effector state, as the normal dampening effects on pathways like mTORC1/c-Myc are lost.
• Chronic Stress Interaction: Under chronic stress, the hypothalamic-pituitary-adrenal (HPA) axis releases glucocorticoids that can cause glucocorticoid resistance in immune cells. This resistance, combined with genetically reduced CTLA-4 signaling, creates a synergistic "immune imbalance" characterized by a Th1/Th17 pro-inflammatory skew and diminished regulatory T-cell (Treg) function.

Bottom line

The CTLA4 rs3087243 A/G variant—specifically the A allele—is scientifically supported as a factor that reduces CTLA-4 surface expression and inhibitory signaling. This impairment weakens adaptive immune checkpoint control, making it plausible that chronic stress further exacerbates immune dysregulation and pro-inflammatory states in carriers of this variant.